The GLP-1 Peptide Weight Loss Injection Pen is a cutting-edge medical device designed for precise subcutaneous medication delivery. This auto-injector pen combines advanced technology with user-friendly features to provide optimal treatment for diabetes management and weight loss therapy.
Key Features:
1. Advanced transmission mechanism minimizes injection force for comfortable use
2. Large, clear dose display window for easy reading
3. Auditory and visual feedback during medication process
4. Ergonomic design for one-handed operation
5. Compatible with standard 3ml cartridges from major manufacturers
6. Automatic injection mechanism with precise dose control
7. Suitable for both insulin and GLP-1 peptide therapies
8. Visual and auditory confirmation when injection is complete
Technical Specifications:
The injection pen features a compact cylindrical design with precise mechanical components that ensure accurate medication delivery. The device includes a dose selector mechanism that allows for fine adjustments in 0.01ml increments, with a maximum single dose capacity of 0.75ml.
The pen's injection mechanism is optimized for medications with viscosity up to 5cP and works with ultra-fine 31G/32G needles for minimal discomfort. The complete injection process takes less than 6 seconds, with precision maintained within ±2% of the selected dose.
Clinical Applications:
This medical device is designed for subcutaneous administration of GLP-1 receptor agonists and insulin formulations. It is particularly suitable for patients requiring regular injections for diabetes management or weight loss therapy, providing a convenient alternative to traditional syringe injections.
The injection pen's design focuses on patient compliance and ease of use, with features that accommodate users with limited dexterity. The clear dose display and confirmation signals help ensure proper medication administration.